tiprankstipranks
Raffles Medical Group Ltd (SG:BSL)
SGX:BSL
Holding SG:BSL?
Track your performance easily

Raffles Medical Group (BSL) Income Statement

71 Followers

Raffles Medical Group Income Statement

Last quarter (Q4 2022), Raffles Medical Group's total revenue was S$―, a decrease of ― from the same quarter last year. In Q4, Raffles Medical Group's net income was S$―. See Raffles Medical Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
-S$ 766.54MS$ 723.79MS$ 568.20MS$ 522.04MS$ 489.13M
Cost of Revenue
-S$ 126.56MS$ 143.27MS$ 135.78MS$ 110.97MS$ 99.52M
Gross Profit
-S$ 639.98MS$ 580.52MS$ 432.43MS$ 411.07MS$ 389.62M
Operating Expense
-S$ 425.82MS$ 457.72MS$ 342.07MS$ 332.82MS$ 302.37M
Operating Income
-S$ 214.16MS$ 122.80MS$ 90.36MS$ 78.25MS$ 87.25M
Net Non Operating Interest Income Expense
-S$ -4.14MS$ -5.72MS$ -4.00MS$ -244.00KS$ -101.00K
Other Income Expense
------
Pretax Income
-S$ 191.70MS$ 115.58MS$ 84.44MS$ 75.92MS$ 84.13M
Tax Provision
-S$ 48.00MS$ 31.87MS$ 19.77MS$ 15.40MS$ 13.33M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-S$ 143.52MS$ 84.17MS$ 65.89MS$ 60.27MS$ 71.06M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-S$ 1.79MS$ 1.74MS$ 2.02MS$ 5.09MS$ 13.33M
Total Expenses
-S$ 552.37MS$ 600.99MS$ 477.85MS$ 443.79MS$ 401.89M
Net Income From Continuing And Discontinued Operation
-S$ 143.52MS$ 84.17MS$ 65.89MS$ 60.27MS$ 71.06M
Normalized Income
-S$ 157.25MS$ 85.25MS$ 67.36MS$ 61.94MS$ 73.59M
Interest Expense
-S$ 6.88MS$ 6.36MS$ 5.15MS$ 1.94MS$ 1.18M
EBIT
-S$ 198.59MS$ 121.94MS$ 89.59MS$ 77.86MS$ 85.32M
EBITDA
-S$ 238.80MS$ 161.27MS$ 125.09MS$ 107.13MS$ 103.59M
Currency in SGD

Raffles Medical Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis